Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Marek

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Neurology|October 15, 2017
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
The Lancet. Neurology|April 9, 2008
The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded studyAlexandra Gaenslen, Barbara Unmuth, Jana Godau, et al.
Annals of Neurology|February 21, 2019
Concordance for Parkinson's disease in twins: A 20-year updateSamuel M Goldman, Kenneth Marek, Ruth Ottman, et al.
Brain : a Journal of Neurology|October 23, 2015
Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-βYoshifumi Maya, Yuki Okumura, Ryohei Kobayashi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 8, 2017
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohortTanya Simuni, Chelsea Caspell-Garcia, Christopher S Coffey, et al.
Neurobiology of Disease|April 30, 2018
Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot studyHua Wang, Anzari Atik, Tessandra Stewart, et al.
Journal of Parkinson'S Disease|May 31, 2024
Occupational Pesticide Exposure in Parkinson's Disease Related to GBA and LRRK2 VariantsEthan G Brown, Samuel M Goldman, Christopher S Coffey, et al.
NPJ Parkinson'S Disease|October 1, 2025
Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and olderKerri A Pierz, Whitley Aamodt, Caroline Gochanour, et al.
JAMA Neurology|December 4, 2023
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson DiseaseShijun Yan, Cheng Jiang, Annette Janzen, et al.
Clinical Parkinsonism & Related Disorders|September 2, 2025
Safety and Feasibility of Serial Lumbar Punctures: Long-term Results from the Parkinson's Progression Markers InitiativeWilliam Barbosa, Ruth B Schneider, Seung Ho Choi, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Neurology|October 15, 2017
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
The Lancet. Neurology|April 9, 2008
The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded studyAlexandra Gaenslen, Barbara Unmuth, Jana Godau, et al.
Annals of Neurology|February 21, 2019
Concordance for Parkinson's disease in twins: A 20-year updateSamuel M Goldman, Kenneth Marek, Ruth Ottman, et al.
Brain : a Journal of Neurology|October 23, 2015
Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-βYoshifumi Maya, Yuki Okumura, Ryohei Kobayashi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 8, 2017
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohortTanya Simuni, Chelsea Caspell-Garcia, Christopher S Coffey, et al.
Neurobiology of Disease|April 30, 2018
Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot studyHua Wang, Anzari Atik, Tessandra Stewart, et al.
Journal of Parkinson'S Disease|May 31, 2024
Occupational Pesticide Exposure in Parkinson's Disease Related to GBA and LRRK2 VariantsEthan G Brown, Samuel M Goldman, Christopher S Coffey, et al.
NPJ Parkinson'S Disease|October 1, 2025
Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and olderKerri A Pierz, Whitley Aamodt, Caroline Gochanour, et al.
JAMA Neurology|December 4, 2023
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson DiseaseShijun Yan, Cheng Jiang, Annette Janzen, et al.
Clinical Parkinsonism & Related Disorders|September 2, 2025
Safety and Feasibility of Serial Lumbar Punctures: Long-term Results from the Parkinson's Progression Markers InitiativeWilliam Barbosa, Ruth B Schneider, Seung Ho Choi, et al.
Pageof 15